I
N. Amri et al.
Feature
Synthesis
(2-Isobutoxy-2-phenylethyl)(phenyl)selane (42)
1-Phenyl-2-(phenylselanyl)ethyl Formate (47)
Compound 42 was synthesised following GP1. It was purified by col-
Compound 47 was synthesised following GP1. It was purified by col-
umn chromatography (silica gel, hexane/ethyl acetate, 30:1).
umn chromatography (silica gel, hexane/ethyl acetate, 4:1).
Yield: 150 mg (75%); yellow oil.
Yield: 76 mg (41%); colourless oil.
The spectral data are in agreement with the literature.10a
The spectral data are in agreement with the literature.10a
1H NMR (400 MHz, CDCl3): = 7.56–7.43 (m, 2 H), 7.38–7.18 (m, 8 H),
4.46 (dd, J = 8.8, 4.8 Hz, 1 H), 3.36 (dd, J = 12.1, 8.8 Hz, 1 H), 3.16–3.01
(m, 3 H), 1.86 (m, 1 H), 0.98–0.81 (m, 6 H).
1H NMR (500 MHz, CDCl3): = 8.00 (s, 1 H), 7.44–7.40 (m, 2 H), 7.30–
7.13 (m, 8 H), 5.94 (dd, J = 8.9, 5.8 Hz, 1 H), 3.32 (dd, J = 12.9, 8.0 Hz, 1
H), 3.18 (dd, J = 13.2, 6.1 Hz, 1 H).
13C NMR (101 MHz, CDCl3): = 142.6, 132.4, 131.2, 129.1, 128.5,
13C NMR (126 MHz, CDCl3): = 160.0, 138.8, 135.5, 133.4, 129.3,
127.9, 126.7, 78.9, 69.9, 36.2, 23.4, 21.5.
128.8, 128.7, 127.5, 126.8, 75.1, 33.2.
[2-(Cyclopentyloxy)-2-phenylethyl](phenyl)selane (43)
1-Phenyl-2-(phenylselanyl)ethyl Acetate (48)
Compound 43 was synthesised following GP1. It was purified by col-
Compound 48 was synthesised following GP1. It was purified by col-
umn chromatography (silica gel, hexane/ethyl acetate, 30:1).
umn chromatography (silica gel, hexane/ethyl acetate, 4:1).
Yield: 148 mg (71%); yellow oil.
Yield: 92 mg (46%); colourless oil.
IR (neat): 3057, 2868, 1476, 1437, 1072, 1022, 732, 700 cm–1
.
The spectral data are in agreement with the literature.10a
1H NMR (500 MHz, CDCl3): = 7.45–7.37 (m, 2 H), 7.29–7.10 (m, 8 H),
4.47 (dd, J = 9.2, 4.4 Hz, 1 H), 3.92–3.52 (m, 1 H), 3.22 (dd, J = 12.2, 9.2
Hz, 1 H), 2.99 (dd, J = 12.2, 4.5 Hz, 1 H), 1.74–1.34 (m, 8 H).
1H NMR (500 MHz, CDCl3): = 7.46–7.40 (m, 2 H), 7.28–7.16 (m, 8 H),
5.87 (dd, J = 8.0, 5.7 Hz, 1 H), 3.31 (dd, J = 12.8, 8.0 Hz, 1 H), 3.16 (dd, J
= 12.8, 5.7 Hz, 1 H), 1.95 (s, 3 H).
13C NMR (126 MHz, CDCl3): = 142.5, 132.4, 131.4, 129.1, 128.6,
13C NMR (126 MHz, CDCl3): = 170.1, 139.5, 133.2, 129.9, 129.2,
127.9, 126.8, 126.7, 79.6, 79.4, 36.2, 33.2, 31.7, 23.5.
128.6, 128.5, 127.3, 126.7, 75.3, 33.5, 21.2.
[2-(Cyclohexyloxy)-2-phenylethyl](phenyl)selane (44)
1-[1-Phenyl-2-(phenylselanyl)ethyl]-1H-benzo[d][1,2,3]triazole (49)
Compound 44 was synthesised following GP1. It was purified by col-
Compound 49 was synthesised following GP1. It was purified by col-
umn chromatography (silica gel, hexane/ethyl acetate, 30:1).
umn chromatography (silica gel, hexane/ethyl acetate, 9:1).
Yield: 135 mg (62%); yellow oil.
Yield: 147 mg (65%); colourless oil.
IR (neat): 2927, 2854, 1477, 1436, 1070, 733, 700 cm–1
.
The spectral data are in agreement with the literature.10a
1H NMR (500 MHz, CDCl3): = 7.40 (m, 2 H), 7.29–7.09 (m, 8 H), 4.57
(dd, J = 9.0, 4.6 Hz, 1 H), 3.24 (dd, J = 12.1, 9.0 Hz, 1 H), 3.16–3.07 (m, 1
H), 2.99 (dd, J = 12.1, 4.6 Hz, 1 H), 1.68 (m, 4 H), 1.42–0.92 (m, 6 H).
1H NMR (500 MHz, CDCl3): = 8.10–7.94 (m, 1 H), 7.46–7.39 (m, 2 H),
7.38–7.19 (m, 11 H), 5.85 (dd, J = 9.4, 5.8 Hz, 1 H), 4.25 (dd, J = 13.1,
9.4 Hz, 1 H), 3.82 (dd, J = 13.1, 5.8 Hz, 1 H).
13C NMR (126 MHz, CDCl3): = 142.8, 132.3, 131.4, 129.1, 128.5,
13C NMR (126 MHz, CDCl3): = 146.1, 138.4, 133.7, 133.1, 129.3,
127.9, 126.7, 126.6, 78.5, 75.7, 36.4, 33.5, 31.4, 25.9, 24.2, 24.0.
129.0, 129.0, 128.8, 127.8, 127.3, 126.9, 124.0, 120.1, 109.6, 63.6, 32.6.
(2-tert-Butoxy-2-phenylethyl)(phenyl)selane (45)
2-[(Phenylselanyl)methyl]tetrahydrofuran (50)
Compound 45 was synthesised following GP1. It was purified by col-
Compound 50 was synthesised following GP2. It was purified by col-
umn chromatography (silica gel, hexane/ethyl acetate, 30:1).
umn chromatography (silica gel, hexane/ethyl acetate, 4:1).
Yield: 93 mg (47%); yellow oil.
Yield: 105 mg (73%); pale yellow oil.
IR (neat): 2972, 2931, 1477, 1436, 1072, 1190, 731, 700 cm–1
.
The spectral data are in agreement with the literature.25
1H NMR (400 MHz, CDCl3): = 7.41–7.31 (m, 2 H), 7.27–7.06 (m, 8 H),
4.60 (dd, J = 8.6, 4.8 Hz, 1 H), 3.14 (dd, J = 12.1, 8.6 Hz, 1 H), 2.95 (dd, J
= 12.1, 4.8 Hz, 1 H), 1.02 (s, 9 H).
13C NMR (101 MHz, CDCl3): = 145.3, 132.2, 131.5, 129.1, 128.4,
127.4, 126.6, 126.3, 75.0, 74.2, 37.4, 28.9.
1H NMR (500 MHz, CDCl3): = 7.59–7.50 (m, 2 H), 7.30–7.22 (m, 3 H),
4.30–4.03 (m, 1 H), 4.01–3.88 (m, 1 H), 3.84–3.66 (m, 1 H), 3.15 (dd, J
= 12.2, 5.8 Hz, 1 H), 3.01 (dd, J = 12.2, 6.9 Hz, 1 H), 2.14–2.05 (m, 1 H),
2.03–1.80 (m, 2 H), 1.65 (m, 1 H).
13C NMR (126 MHz, CDCl3): = 137.4, 132.7, 129.2, 127.0, 78.4, 78.4,
33.2, 31.7, 26.1.
1-Phenyl-2-(phenylselanyl)ethan-1-ol (46)
2-[(Phenylselanyl)methyl]tetrahydro-2H-pyran (51)
Compound 46 was synthesised following GP1. It was purified by col-
umn chromatography (silica gel, hexane/ethyl acetate, 9:1).
Compound 51 was synthesised following GP2. It was purified by col-
umn chromatography (silica gel, hexane/ethyl acetate, 4:1).
Yield: 134 mg (81%); colourless oil.
Yield: 103 mg (67%); pale yellow oil.
The spectral data are in agreement with the literature.25
1H NMR (500 MHz, CDCl3): = 7.55–7.46 (m, 2 H), 7.29–7.18 (m, 3 H),
4.04–3.95 (m, 1 H), 3.92–3.26 (m, 2 H), 3.07 (dd, J = 12.2, 6.9 Hz, 1 H),
2.93 (dd, J = 12.2, 5.7 Hz, 1 H), 1.99–1.68 (m, 2 H), 1.61–1.43 (m, 3 H),
1.37–1.26 (m, 1 H).
The spectral data are in agreement with the literature.10a
1H NMR (500 MHz, CDCl3): = 7.60–7.51 (m, 2 H), 7.38–7.32 (m, 4 H),
7.32–7.26 (m, 4 H), 4.76 (dd, J = 9.4, 3.5 Hz, 1 H), 3.31 (dd, J = 12.8, 3.7
Hz, 1 H), 3.15 (dd, J = 12.8, 9.4 Hz, 1 H), 2.79 (s, 1 H).
13C NMR (126 MHz, CDCl3): = 142.6, 133.3, 129.4, 129.3, 128.7,
128.1, 127.6, 125.9, 72.4, 38.6.
© 2020. Thieme. All rights reserved. Synthesis 2020, 52, A–K